Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), ratio decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), ratio decreased (Expand Search)
-
1901
Topographic maps of difference in alpha functional connectivity between breathing conditions.
Published 2025Subjects: -
1902
-
1903
Topographic maps of difference in theta power between breathing conditions.
Published 2025Subjects: -
1904
-
1905
Difference in alpha power between breathing conditions for left and right central-parietal ROI.
Published 2025Subjects: -
1906
Topographic maps of difference in individual alpha/mu power between breathing conditions.
Published 2025Subjects: -
1907
-
1908
-
1909
Difference in theta power between breathing conditions for frontal midline ROI.
Published 2025Subjects: -
1910
-
1911
Topographic maps of difference in theta functional connectivity between breathing conditions.
Published 2025Subjects: -
1912
-
1913
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
1914
-
1915
-
1916
-
1917
-
1918
-
1919
-
1920